Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q4 2019 (← Previous) (Next →)
Filing Date: Feb 14, 2020
Total Value: $2.506B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | TURNING POINT THERAPEUTICS I | 3,396,650 | $212M | 8.4% | $40.33 | — | COM | 90041T108 |
| — | REATA PHARMACEUTICALS INC | 816,400 | $167M | 6.7% | $55.95 | — | CL A | 75615P103 |
| — | MIRATI THERAPEUTICS INC | 1,282,392 | $165M | 6.6% | $38.92 | — | COM | 60468T105 |
| — | CHEMOCENTRYX INC | 2,900,000 | $115M | 4.6% | $23.45 | — | COM | 16383L106 |
| — | PRINCIPIA BIOPHARMA INC | 1,990,922 | $109M | 4.4% | $37.55 | — | COM | 74257L108 |
| — | CONSTELLATION PHARMCETICLS I | 2,300,000 | $108M | 4.3% | $25.81 | — | COM | 210373106 |
| BBIO | BRIDGEBIO PHARMA INC | 2,512,865 | $88.08M | 3.5% | $27.26 | +1.7% | COM | 10806X102 |
| APLS | APELLIS PHARMACEUTICALS INC | 2,700,000 | $82.67M | 3.3% | $15.50 | +78.5% | COM | 03753U106 |
| — | MIRATI THERAPEUTICS INC | 500,000 | $64.43M | 2.6% | $38.92 | — | Call | 60468T105 |
| AXSM | AXSOME THERAPEUTICS INC | 600,000 | $62.02M | 2.5% | $40.39 | 0.0% | COM | 05464T104 |
| CRSP | CRISPR THERAPEUTICS AG | 1,000,000 | $60.91M | 2.4% | $39.27 | +39.0% | NAMEN AKT | H17182108 |
| — | NEXTCURE INC | 1,000,000 | $56.33M | 2.2% | $19.75 | — | COM | 65343E108 |
| ASND | ASCENDIS PHARMA A S | 400,000 | $55.65M | 2.2% | $79.53 | — | SPONSORED ADR | 04351P101 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 1,000,000 | $54.44M | 2.2% | $41.49 | — | COM | G11196105 |
| — | REATA PHARMACEUTICALS INC | 250,000 | $51.11M | 2.0% | $55.95 | — | Call | 75615P103 |
| — | MYOKARDIA INC | 700,000 | $51.02M | 2.0% | $37.76 | — | COM | 62857M105 |
| STOK | STOKE THERAPEUTICS INC | 1,788,643 | $50.65M | 2.0% | $26.85 | -6.3% | COM | 86150R107 |
| — | Y-MABS THERAPEUTICS INC | 1,602,376 | $50.07M | 2.0% | $27.98 | — | COM | 984241109 |
| XBI | SPDR SERIES TRUST | 500,000 | $47.55M | 1.9% | — | — | Put | 78464A870 |
| RCKT | ROCKET PHARMACEUTICALS INC | 1,837,269 | $41.82M | 1.7% | $16.47 | +1.4% | COM | 77313F106 |
| — | VIELA BIO INC | 1,497,500 | $40.66M | 1.6% | $27.15 | — | COM | 926613100 |
| — | TRICIDA INC | 927,975 | $35.02M | 1.4% | $33.32 | — | COM | 89610F101 |
| ASND | ASCENDIS PHARMA A S | 250,000 | $34.78M | 1.4% | $79.53 | — | Call | 04351P101 |
| — | AXONICS MODULATION TECH INC | 1,222,671 | $33.88M | 1.4% | $15.11 | — | COM | 05465P101 |
| — | QUOTIENT LTD | 3,500,000 | $33.28M | 1.3% | $8.95 | — | SHS | G73268107 |
| SRPT | SAREPTA THERAPEUTICS INC | 250,000 | $32.26M | 1.3% | $124.50 | -18.9% | COM | 803607100 |
| — | ZYMEWORKS INC | 700,000 | $31.82M | 1.3% | $45.46 | — | COM | 98985W102 |
| — | MYOVANT SCIENCES LTD | 2,000,000 | $31.04M | 1.2% | $15.52 | — | COM | G637AM102 |
| CABA | CABALETTA BIO INC | 2,119,132 | $29.6M | 1.2% | $11.85 | 0.0% | COM | 12674W109 |
| QURE | UNIQURE NV | 400,000 | $28.66M | 1.1% | $61.71 | -11.0% | SHS | N90064101 |
| — | ALLAKOS INC | 300,000 | $28.61M | 1.1% | $42.85 | — | COM | 01671P100 |
| — | EIDOS THERAPEUTICS INC | 495,692 | $28.45M | 1.1% | $21.18 | — | COM | 28249H104 |
| — | DECIPHERA PHARMACEUTICALS IN | 450,000 | $28.01M | 1.1% | $33.94 | — | COM | 24344T101 |
| — | AMARIN CORP PLC | 1,300,000 | $27.87M | 1.1% | $15.29 | — | SPONS ADR NEW | 023111206 |
| — | BLUEPRINT MEDICINES CORP | 345,000 | $27.64M | 1.1% | $70.46 | — | COM | 09627Y109 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 500,000 | $27.22M | 1.1% | $41.49 | — | Call | G11196105 |
| — | IMMUNOVANT INC | 1,080,000 | $26.55M | 1.1% | $24.58 | — | UNIT 12/18/2024 | 45258J201 |
| OMER | OMEROS CORP | 1,525,000 | $21.49M | 0.9% | $14.64 | 0.0% | COM | 682143102 |
| GLPG | GALAPAGOS NV | 100,000 | $20.92M | 0.8% | $116.55 | — | SPON ADR | 36315X101 |
| — | SATSUMA PHARMACEUTICALS INC | 858,382 | $16.89M | 0.7% | $15.01 | — | COM | 80405P107 |
| — | AKERO THERAPEUTICS INC | 740,621 | $16.44M | 0.7% | $19.15 | — | COM | 00973Y108 |
| ARGX | ARGENX SE | 100,000 | $16.05M | 0.6% | $82.17 | — | SPONSORED ADR | 04016X101 |
| TWST | TWIST BIOSCIENCE CORP | 687,149 | $14.43M | 0.6% | $22.16 | +5.6% | COM | 90184D100 |
| — | MERUS N V | 1,000,000 | $14.08M | 0.6% | $14.08 | — | COM | N5749R100 |
| — | RA PHARMACEUTICALS INC | 295,600 | $13.87M | 0.6% | $18.20 | — | COM | 74933V108 |
| KURA | KURA ONCOLOGY INC | 1,000,000 | $13.75M | 0.5% | $14.56 | +1.8% | COM | 50127T109 |
| SRNE | SORRENTO THERAPEUTICS INC | 4,000,000 | $13.52M | 0.5% | $2.38 | 0.0% | COM NEW | 83587F202 |
| INSP | INSPIRE MED SYS INC | 172,300 | $12.79M | 0.5% | $32.28 | +99.1% | COM | 457730109 |
| — | EIGER BIOPHARMACEUTICALS INC | 833,400 | $12.42M | 0.5% | $10.60 | — | COM | 28249U105 |
| ZLAB | ZAI LAB LTD | 277,161 | $11.53M | 0.5% | $22.58 | — | ADR | 98887Q104 |
| — | CHEMOCENTRYX INC | 250,000 | $9.888M | 0.4% | $23.45 | — | Call | 16383L106 |
| — | HARPOON THERAPEUTICS INC | 649,994 | $9.613M | 0.4% | $9.47 | — | COM | 41358P106 |
| — | ARENA PHARMACEUTICALS INC | 172,300 | $7.826M | 0.3% | $42.46 | — | COM NEW | 040047607 |
| — | PRECISION BIOSCIENCES INC | 467,516 | $6.494M | 0.3% | $17.95 | — | COM | 74019P108 |
| — | AVROBIO INC | 317,579 | $6.393M | 0.3% | $21.11 | — | COM | 05455M100 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 479,988 | $6.336M | 0.3% | $31.47 | — | SPON ADS | 05280R100 |
| — | IGM BIOSCIENCES INC | 156,400 | $5.968M | 0.2% | $17.75 | — | COM | 449585108 |
| ANAB | ANAPTYSBIO INC | 365,000 | $5.931M | 0.2% | $39.24 | -39.7% | COM | 032724106 |
| — | ATRECA INC | 326,141 | $5.045M | 0.2% | $18.84 | — | CL A COM | 04965G109 |
| — | ORCHARD THERAPEUTICS PLC | 350,203 | $4.815M | 0.2% | $16.35 | — | ADS | 68570P101 |
| GOSS | GOSSAMER BIO INC | 300,000 | $4.689M | 0.2% | $20.85 | -3.4% | COM | 38341P102 |
| — | MINERVA NEUROSCIENCES INC | 607,903 | $4.322M | 0.2% | $7.26 | — | COM | 603380106 |
| — | NEKTAR THERAPEUTICS | 200,000 | $4.317M | 0.2% | $44.47 | — | COM | 640268108 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 39,300 | $4.224M | 0.2% | $31.24 | +235.1% | COM | 64125C109 |
| — | X4 PHARMACEUTICALS INC | 252,747 | $2.704M | 0.1% | $15.68 | — | COM | 98420X103 |
| TBPH | THERAVANCE BIOPHARMA INC | 50,000 | $1.295M | 0.1% | $19.43 | 0.0% | COM | G8807B106 |
| — | OUTLOOK THERAPEUTICS INC | 416,666 | $27,000 | 0.0% | $0.15 | — | *W EXP 02/18/202 | 69012T115 |